| INTRODUCTION
Inappropriate use of antibiotics increases antibiotic resistance leading to increases in morbidity, mortality and costs of treatment.
1-5 This is not helped by the fact that in most sub-Saharan countries, antibiotic treatment policies are not up-to-date, and there can be high rates of self-purchasing of antibiotics, leading to increased antimicrobial resistance to essential antibiotics. [6] [7] [8] [9] [10] [11] This has had a devastating impact on public health in the sub-Saharan Africa. [12] [13] [14] [15] [16] However, effective policies including education of all key stakeholder groups, prescribing restrictions as well as indicators have enhanced the appropriate use of antibiotics.
14, [17] [18] [19] [20] In Namibia, despite the scale-up of medicine use systems and policies (Table 1) , 12, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] antibiotic use and policy compliance indicators in the public health sector remain suboptimal. 6, [31] [32] [33] As a result, there has been growing resistance to essential antimicrobials used at public health facilities in Namibia and sub-Saharan Africa; with a similar situation for antimalarials. These include chloroquine, 34, 35 cotrimoxazole, [36] [37] [38] [39] [40] [41] [42] sulphadoxine/pyrimethamine 2 and ampicillin. [43] [44] [45] [46] Reports from the Namibia's National Institute of Pathology (NIP) have also indicated increasing incidence of antibiotic resistance to first-line antibiotics particularly cotrimoxazole, azithromycin and amoxicillin (CAA), ranging between 55.9%-96.7%. 36, 39, 47, 48 Despite the heightening resistance to CAA in Namibia, ABC (Pareto) analyses on expenditure of medicines and medicine use surveys at public health facilities in Namibia continue to rank CAA antibiotics among the top 15 expenditure items or top three antibiotics. 6, 21, 32, 49 One of the factors driving increased prescribing of antibiotics in Namibia is the burden of infectious diseases particularly HIV/ AIDS, 6, 32, 33, 36, 39 which may well aggravate resistance to essential antibiotics. 12, 14, 50 Of concern are the primary healthcare centres (PHC) 32, [51] [52] [53] [54] [55] [56] with gaps in laboratory diagnostics, education regarding appropriate antibiotic use and human capacity. 5, 6, 31 Among PHCs, the risk of antibiotic misuse is exacerbated by the high workload for health workers with limited training on antibiotic pharmacotherapy as recommended by WHO and Medicines and related Act of Namibia.
57-61
In addition, only one indicator, HF 13, regarding the number of antibiotics per prescription is used to monitor antibiotic use in Namibia. 
| AIMS
Consequently, we sought to address this by developing and evaluating antibiotic use indicators at a policy level in Namibia as the first step to improve future antibiotic use in ambulatory care in Namibia. Box 1 contains details of the current systems and policies in Namibia.
What's known
• There is considerable overuse of common antibiotics across countries particularly in primary healthcare centres leading to increasing resistance rate.
• There are ongoing developments to improve the use of antibiotics across countries including general and specific guidelines, treatment guidelines, essential medicine lists and quality indicators for antibiotics. In addition, growing surveillance of antibiotic resistance patterns to guide the empiric use of antibiotics.
• However, there can be concerns that the various groups producing prescribing guidance are not co-ordinated.
What's new
• Novel way for low-and middle-income countries to assess utilisation of common antibiotics against treatment guidelines, quality indicators and essential medicine lists especially where there are concerns with antibiotic resistance patterns.
• There appeared to be no co-ordination in Namibia between the various government bodies producing treatment guidelines, essential medicine lists and monitoring resistance patterns; resulting in continued high use of common antibiotics across multiple conditions exacerbating resistance rates.
• Several antibiotics were also listed in essential medicine lists but not included in any guidelines. This has implications for their misuse, which needs to be addressed.
T A B L E 1 Policy indicators for antibiotic use

Policy indicator Thresh hold Status
Availability and access to key antibiotic policy documents % of policy documents with policies on antibiotic use 
| MATERIALS AND METHODS
| Medicine policy documents
We 
| Methods
Quantitative policy analysis methods were used to evaluate pharmaceutical policy indicators for antibiotic use. 
| Ethical considerations
The study has no ethical implications as no human subjects were interviewed or recruited in this study. The study adopted a policy document analysis approach where secondary data were used from policy
Box 1 Systems and policies for medicine use in Namibia
Pharmaceutical Systems in Namibia:
• Pharmaceutical Management information system (PMIS): A system implemented in all hospital and public health facilities for reporting on performance and monitoring human resources for pharmacy and medicine indicators. This is implemented by the Ministry of Health and Social Services -Pharmaceutical division.
• Electronic database systems: including the electronic dispensing tool, the stock card Dashboard, the TB manager and the Rx solution to collect monthly data on the use of medicines at public health facility.
• Access to essential medicines: An updated Namibia essential medicine list provides for the level of use of various medicines, all of which are accessed free at public health facilities.
Policies:
• Namibia Medicine policy: provides a framework for access and availability to safe, efficacious and cost-effective medicines to the population and the rational use of medicines. documents which are all accessible for use by the public. All extracts from the policy documents have been referenced.
| RESULTS
| Policy indicators for antibiotic use
Only the MoHSS HF-13 indicator is currently used to measure antibiotic use in Namibia 49 at the health facility level. Five policy indicators for measuring effective and safe antibiotic use were developed based approaches by Brown 64 and evaluated (Table 1) .
These indicators assessed the implementation of antibiotic policies across sectors. They were developed based on access, availability and use of antibiotics as described by the Namibian medicine policy statements for the general use of medicines. These indicators focus on both access and availability of antibiotic policy documents at the National level and their implementation at the points of access of antibiotics.
| Current antibiotic policies in Namibia
A total of seven policy documents were reviewed for policies on anti- 
| Factors associated with indications for CAA antibiotics
Treatment policies indicated the prescribing of CAA antibiotics for the treatment of respiratory, musculoskeletal, gastrointestinal and 
| The standards in the STG criteria for use of CAA antibiotics
Azithromycin and amoxicillin are selectively indicated for treatment of 90% of respiratory tract infections in the STGs, including upper respiratory infections that are commonly of a viral aetiology 61 and to manage secondary bacterial infections. 23 Cotrimoxazole is recommended for prophylaxis against PCP and other types of pneumonia in HIV/AIDS patients.
| DISCUSSION
Despite the existence of guidelines for antibiotic use in various treatment guidelines in Namibia including HIV/AIDS, malaria and tuberculosis as well as the integrated management of childhood illnesses in Namibia [22] [23] [24] [25] [26] [27] (Table 1) , Namibia has no comprehensive antibiotic policy, antibiotic guidelines, antibiotic formulary or antibiograms.
These strategies provide the evidence based for the appropriate use of antibiotics. 10, 45, 60, 62, 65, 66 Previous studies in Namibia on antibiotic use have recommended the development of guidelines specific to antibiotics in both the private and public sectors. 6, [31] [32] [33] Unfortunately, to date, only the draft National medicine policy has a policy statement on antibiotics which is mentioned in a passive way. (Table 1 and Figure 1) . 6 The over use of CAA antibiotics due to policy indications may cause selective pressure for antimicrobial resistance, and irrational practices may exacerbate the problem. 2, 4, 6, 12 Sensitivity reports have reported a rising resistance to CAA ranging between 58% and 95.6%. 4, 31 This needs to be addressed to enhance the effectiveness of these important antibiotics. This includes addressing suboptimal adherence to good prescribing practices that have been reported in medicine use surveys in Namibia and addressing poor indicators of good antibiotic prescribing such as number of antibiotics per prescription, which is currently seen as to high in Namibia across all sectors. 6, 32, 33, 49 In addition, three antibiotics ( between the essential medicines list and the treatment guidelines may lead to inappropriate use and limited access of antibiotics. This needs to be resolved.
In Namibia, there are also currently two committees for the essential medicines list and treatment guidelines, which work in parallel.
This may lead to policy duplication or omissions, both potentially causing negative consequences on access and therapeutic outcomes. 22, 23 This again needs to be looked at to improve future antibiotic use.
This study found that medicine policies indicate all the CAA antibiotics for use at all levels of healthcare in Namibia including primary healthcare (Table 1) for both curative and preventative programmes.
In primary healthcare, cotrimoxazole is indicated for HIV/AIDS-related infections and amoxicillin in presumptive prophylaxis in malnutrition.
Overall, CAA antibiotics are indicated for use in 75% (9/11) of indi- reported that 69.6% of the prescribers do not comply with guidelines and formularies on the basis of right antibiotic indication, dose and duration. This may be because of the issues of lack of knowledge regarding appropriate antibiotic prescribing with physicians in a recent systematic review requesting educational input to improve their prescribing. 43 Medicine policies and guidelines in Namibia currently indicate the use of CAA antibiotics for most respiratory, urogenital, musculoskeletal and gastrointestinal infections, and disease conditions that are highly prevalent at PHCs in Namibia (Table 3) . [22] [23] [24] [25] [26] [27] . The study by Kunda 37 indicates high use of antibiotics in URTIs of up to 78% in Namibia, which needs to be addressed given the high percentage of URTIs that are viral in origin. Cotrimoxazole is indicated for management of bloody diarrhoea. However, the NIP antibiogram shows up to 90% resistance levels of most bacteria common in respiratory and urinary tract infections such as S. aureus, S. pneumoniae and E. coli to amoxicillin and cotrimoxazole. 47 Consequently, there is a need to revise the guidelines as well as instigate policies that reduce resistance rates to these effective antibiotics. The latter potentially includes extensive educational initiatives including patients.
| CONCLUSIONS AND RECOMMENDATIONS
Policy indicators for antibiotic use are suboptimal in Namibia and may be an important driver in the current overuse of CAA antibiotics in Namibia.
Overall, Namibia currently lacks a comprehensive antibiotic policy and up-to-date guidelines, formulary and antibiograms. This may negatively impact on evidence based empiric therapy at all levels of care, which is a concern given current high resistance rates to CAA antibiotics.
There are also concerns with the lack of coherence between the We also believe our methodology of combining an analysis of current policy documents including formularies, antibiotic prescribing behaviour and resistance patterns is applicable to other lower-and middle-income countries as they strive to improve their antibiotic use.
We will be monitoring developments in Namibia in the future as part of continuing research activities in this critical area.
